California Public Employees Retirement System Sells 7,263 Shares of STERIS plc (NYSE:STE)

California Public Employees Retirement System trimmed its holdings in shares of STERIS plc (NYSE:STE - Free Report) by 4.4% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 159,440 shares of the medical equipment provider's stock after selling 7,263 shares during the period. California Public Employees Retirement System owned 0.16% of STERIS worth $32,774,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors have also recently bought and sold shares of STE. Principal Financial Group Inc. lifted its stake in shares of STERIS by 9.5% in the 3rd quarter. Principal Financial Group Inc. now owns 1,114,224 shares of the medical equipment provider's stock valued at $270,230,000 after purchasing an additional 96,336 shares during the period. Public Sector Pension Investment Board increased its holdings in STERIS by 13.2% in the third quarter. Public Sector Pension Investment Board now owns 4,283 shares of the medical equipment provider's stock valued at $1,039,000 after purchasing an additional 500 shares during the last quarter. Atom Investors LP lifted its stake in STERIS by 37.8% in the third quarter. Atom Investors LP now owns 3,716 shares of the medical equipment provider's stock valued at $901,000 after buying an additional 1,020 shares during the period. Hilltop Holdings Inc. bought a new position in STERIS during the third quarter worth about $218,000. Finally, Investment Management Corp of Ontario grew its position in shares of STERIS by 55.4% during the 3rd quarter. Investment Management Corp of Ontario now owns 3,365 shares of the medical equipment provider's stock worth $816,000 after buying an additional 1,200 shares during the period. 94.69% of the stock is owned by institutional investors.

Remove Ads

STERIS Stock Up 0.0 %

Shares of STE stock traded up $0.01 during trading hours on Monday, hitting $212.62. 949,416 shares of the company were exchanged, compared to its average volume of 534,828. STERIS plc has a 52 week low of $197.82 and a 52 week high of $248.24. The company has a current ratio of 2.13, a quick ratio of 1.40 and a debt-to-equity ratio of 0.32. The business has a 50 day moving average of $223.05 and a two-hundred day moving average of $220.26. The company has a market capitalization of $20.89 billion, a PE ratio of 45.14 and a beta of 0.87.

STERIS (NYSE:STE - Get Free Report) last released its earnings results on Wednesday, February 5th. The medical equipment provider reported $2.32 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $2.33 by ($0.01). STERIS had a return on equity of 13.91% and a net margin of 8.66%. Analysts anticipate that STERIS plc will post 9.08 earnings per share for the current fiscal year.

STERIS Dividend Announcement

The company also recently declared a quarterly dividend, which was paid on Friday, March 21st. Shareholders of record on Thursday, February 20th were given a dividend of $0.57 per share. This represents a $2.28 dividend on an annualized basis and a yield of 1.07%. The ex-dividend date was Thursday, February 20th. STERIS's dividend payout ratio (DPR) is currently 48.41%.

Analyst Ratings Changes

Several research firms recently weighed in on STE. Piper Sandler lifted their price objective on shares of STERIS from $260.00 to $265.00 and gave the stock an "overweight" rating in a research note on Monday, February 3rd. Stephens reissued an "overweight" rating and set a $240.00 price target on shares of STERIS in a research report on Thursday, February 6th. Needham & Company LLC restated a "hold" rating on shares of STERIS in a research report on Monday. Finally, JMP Securities reiterated a "market outperform" rating and set a $265.00 target price on shares of STERIS in a report on Thursday, February 6th. One research analyst has rated the stock with a hold rating and five have assigned a buy rating to the company's stock. According to data from MarketBeat, STERIS has an average rating of "Moderate Buy" and an average target price of $258.75.

STERIS Company Profile

STERIS plc provides infection prevention products and services worldwide. It operates through four segments: Healthcare, Applied Sterilization Technologies, Life Sciences, and Dental. The Healthcare segment offers cleaning chemistries and sterility assurance products; automated endoscope reprocessing system and tracking products; endoscopy accessories, washers, sterilizers, and other pieces of capital equipment for the operation of a sterile processing department; and equipment used directly in the operating room, including surgical tables, lights, and connectivity solutions, as well as equipment management services.